Bioactive Compounds
-
BA1835 AB-836Summary: AB-836 is an orally active coat inhibitor. -
C5120 D-myo-Inositol-1-phosphate (sodium salt)Summary: An intermediate metabolite in the inositol metabolism and signal transduction pathway. -
BA3302 PT-262Summary: PT-262 is a potent inhibitor with a value of approximately 5 μM. -
BA1834 ElebsiranSummary: An siRNA against hepatitis B virus and hepatitis D virus (HDV) infection. -
C5055 Dimethyl biphenyl-4,4'-dicarboxylateSummary: A hepatoprotective research compound derived from Schisandra chinensis that induces the IFN signaling pathway. -
BA3294 AZA197Summary: AZA197 is a selective small molecule inhibitor. -
BA1833 AT-130Summary: AT-130, a phenylacrylamide derivative, is a potent non-nucleoside inhibitor of hepatitis B virus replication. -
C4987 phospho-Linoleoyl EthanolamideSummary: A phosphorylated precursor involved in lipid signaling pathways and the regulation of feeding behavior. -
BA3234 SSE15206Summary: SSE15206 is a microtubule polymerization inhibitor. -
BA1832 HBF-0259Summary: HBF-0259 is a potent and selective inhibitor of hepatitis B virus surface antigen (HBsAg) secretion.

